company background image
6CMB logo

Croda International DB:6CMB Stock Report

Last Price

€56.50

Market Cap

€7.9b

7D

2.7%

1Y

-22.1%

Updated

27 Mar, 2024

Data

Company Financials +

6CMB Stock Overview

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America.

6CMB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Croda International Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Croda International
Historical stock prices
Current Share PriceUK£56.50
52 Week HighUK£80.00
52 Week LowUK£46.60
Beta0.71
1 Month Change-0.88%
3 Month Change-3.42%
1 Year Change-22.07%
3 Year Change-24.16%
5 Year Changen/a
Change since IPO540.06%

Recent News & Updates

Recent updates

Shareholder Returns

6CMBDE ChemicalsDE Market
7D2.7%2.2%2.5%
1Y-22.1%6.5%7.0%

Return vs Industry: 6CMB underperformed the German Chemicals industry which returned 7.1% over the past year.

Return vs Market: 6CMB underperformed the German Market which returned 7.3% over the past year.

Price Volatility

Is 6CMB's price volatile compared to industry and market?
6CMB volatility
6CMB Average Weekly Movement4.9%
Chemicals Industry Average Movement4.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 6CMB has not had significant price volatility in the past 3 months.

Volatility Over Time: 6CMB's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19255,852Steve Footshttps://www.croda.com

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.

Croda International Plc Fundamentals Summary

How do Croda International's earnings and revenue compare to its market cap?
6CMB fundamental statistics
Market cap€7.91b
Earnings (TTM)€199.61m
Revenue (TTM)€1.98b

39.6x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6CMB income statement (TTM)
RevenueUK£1.69b
Cost of RevenueUK£964.50m
Gross ProfitUK£730.00m
Other ExpensesUK£559.00m
EarningsUK£171.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Jul 30, 2024

Earnings per share (EPS)1.23
Gross Margin43.08%
Net Profit Margin10.09%
Debt/Equity Ratio26.4%

How did 6CMB perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

89%

Payout Ratio

Does 6CMB pay a reliable dividends?

See 6CMB dividend history and benchmarks
When do you need to buy 6CMB by to receive an upcoming dividend?
Croda International dividend dates
Ex Dividend DateApr 18 2024
Dividend Pay DateMay 29 2024
Days until Ex dividend21 days
Days until Dividend pay date62 days

Does 6CMB pay a reliable dividends?

See 6CMB dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.